FDA Rejects Review of Moderna's New mRNA Flu Vaccine: What Happened?

Vinay Prasad, FDA's biologics director, overruled staff to refuse reviewing Moderna's new mRNA flu vaccine, citing trial design issues. HHS denies overruling occurred amid ongoing debate on vaccine scrutiny.